Advertisement

Digestive Diseases and Sciences

, Volume 56, Issue 12, pp 3517–3524 | Cite as

Alpha-Defensin DEFA1A3 Gene Copy Number Elevation in Danish Crohn’s Disease Patients

  • Cathrine Jespersgaard
  • Peder Fode
  • Marianne Dybdahl
  • Ida Vind
  • Ole Haagen Nielsen
  • Claudio Csillag
  • Pia Munkholm
  • Ben Vainer
  • Lene Riis
  • Margarita Elkjaer
  • Natalia Pedersen
  • Elisabeth Knudsen
  • Paal Skytt Andersen
Original Article

Abstract

Background and Purpose of Study

Extensive copy number variation is observed for the DEFA1A3 gene encoding alpha-defensins 1–3. The objective of this study was to determine the involvement of alpha-defensins in colonic tissue from Crohn’s disease (CD) patients and the possible genetic association of DEFA1A3 with CD.

Methods

Two-hundred and forty ethnic Danish CD patients were included in the study. Reverse transcriptase PCR assays determined DEFA1A3 expression in colonic tissue from a subset of patients. Immunohistochemical analysis identified alpha-defensin peptides in colonic tissue. Copy number of DEFA1A3 and individual alleles, DEFA1 and DEFA3, were compared with those for controls, by use of combined real-time quantitative PCR and pyrosequencing, and correlated with disease location.

Results

Inflammatory-dependent mRNA expression of DEFA1A3 (P < 0.001), and the presence of alpha-defensin peptides, were observed in colonic tissue samples. Higher DEFA1A3 gene copy number (CD: mean copy number, 7.2 vs. controls 6.7; P < 0.001) and individual DEFA1 alleles (CD mean copy number 5.6 vs. controls 5.1; P < 0.01) were associated with CD, with strong association with colonic location (P < 0.001).

Conclusions

Alpha-defensins are involved in the inflammation of CD, with local mRNA and peptide expression. In combination with the findings that a high DEFA1A3 copy number is significantly linked to CD, these results suggest that a high DEFA1A3 copy number might be important in hindering the normal inflammatory response in CD, particularly colonic CD.

Keywords

Crohn’s disease Colonic tissue Copy number variation Defensin Genetic association Real-time PCR 

Notes

Acknowledgments

We thank Britta Hansen and Ida Haugaard Bøtcher for expert technical assistance. We would also like to thank Dr John Armour (University of Nottingham, UK) for kindly providing us with data for DEFA1A3 controls, and Nathaniel and Anne Hong for carefully revising the manuscript. This study was supported by the Danish Colitis and Crohn Association, the Augustinus Foundation, Aase and Ejner Danielsens Foundation, the Lundbeck Foundation, the LEO-Pharma Foundation, The Idella Foundation, and “Fonden til Lægevidenskabens Fremme.”.

Conflict of interest

None.

Ethical considerations

The study was conducted according to the Declaration of Helsinki and was approved by the Regional Scientific Ethics Committee. All patients included to the study had given their written consent.

Supplementary material

10620_2011_1794_MOESM1_ESM.doc (211 kb)
Reproducibility of the assay. The graph shows the four controls used in each run plotting the expected copy numbers along the X axis and the observed copy numbers along the Y-axis. The plot illustrates 8 runs. For each run linear regression was performed and the equation for the line was calculated. The figure shows the reproducibility of the assay indicating the standard deviation (SD): TT0296 (Expected CN = 9) SD = 0.14; AF0105 (Expected CN = 7) SD = 0.17; AF0111 (Expected CN = 8) SD = 0.25; AF0103 (Expected CN = 6) SD = 0.08 (DOC 211 kb)

References

  1. 1.
    Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.PubMedCrossRefGoogle Scholar
  2. 2.
    Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606.PubMedCrossRefGoogle Scholar
  3. 3.
    Lees CW, Satsangi J. Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev Gastroenterol Hepatol. 2009;3:513–534.PubMedCrossRefGoogle Scholar
  4. 4.
    Yang D, de la RG, Tewary P, Oppenheim JJ. Alarmins link neutrophils and dendritic cells. Trends Immunol. 2009;30:531–537.PubMedCrossRefGoogle Scholar
  5. 5.
    Leitch GJ, Ceballos C. A role for antimicrobial peptides in intestinal microsporidiosis. Parasitology. 2009;136:175–181.PubMedCrossRefGoogle Scholar
  6. 6.
    Schneider JJ, Unholzer A, Schaller M, Schafer-Korting M, Korting HC. Human defensins. J Mol Med. 2005;83:587–595.PubMedCrossRefGoogle Scholar
  7. 7.
    Ericksen B, Wu Z, Lu W, Lehrer RI. Antibacterial activity and specificity of the six human alpha-defensins. Antimicrob Agents Chemother. 2005;49:269–275.PubMedCrossRefGoogle Scholar
  8. 8.
    Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3:710–720.PubMedCrossRefGoogle Scholar
  9. 9.
    Chertov O, Michiel DF, Xu L, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem. 1996;271:2935–2940.PubMedCrossRefGoogle Scholar
  10. 10.
    Boniotto M, Jordan WJ, Eskdale J, et al. Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob Agents Chemother. 2006;50:1433–1441.PubMedCrossRefGoogle Scholar
  11. 11.
    Grutkoski PS, Graeber CT, Lim YP, Ayala A, Simms HH. Alpha-defensin 1 (human neutrophil protein 1) as an antichemotactic agent for human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 2003;47:2666–2668.PubMedCrossRefGoogle Scholar
  12. 12.
    O’Neil DA, Porter EM, Elewaut D, et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol. 1999;163:6718–6724.PubMedGoogle Scholar
  13. 13.
    Nuding S, Fellermann K, Wehkamp J, Stange EF. Reduced mucosal antimicrobial activity in Crohn’s disease of the colon. Gut. 2007;56:1240–1247.PubMedCrossRefGoogle Scholar
  14. 14.
    Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn’s disease. Proc Natl Acad Sci USA. 2005;102:18129–18134.PubMedCrossRefGoogle Scholar
  15. 15.
    Soehnlein O, Kai-Larsen Y, Frithiof R, et al. Neutrophil primary granule proteins HBP and HNP1–3 boost bacterial phagocytosis by human and murine macrophages. J Clin Invest. 2008;118:3491–3502.PubMedCrossRefGoogle Scholar
  16. 16.
    Sthoeger ZM, Bezalel S, Chapnik N, Asher I, Froy O. High alpha-defensin levels in patients with systemic lupus erythematosus. Immunology. 2009;127:116–122.PubMedCrossRefGoogle Scholar
  17. 17.
    Yamaguchi N, Isomoto H, Mukae H, et al. Concentrations of alpha- and beta-defensins in plasma of patients with inflammatory bowel disease. Inflamm Res. 2009;58:192–197.PubMedCrossRefGoogle Scholar
  18. 18.
    Cunliffe RN, Kamal M, Rose FR, James PD, Mahida YR. Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J Clin Pathol. 2002;55:298–304.PubMedCrossRefGoogle Scholar
  19. 19.
    Linzmeier R, Ho CH, Hoang BV, Ganz T. A 450-kb contig of defensin genes on human chromosome 8p23. Gene. 1999;233:205–211.PubMedCrossRefGoogle Scholar
  20. 20.
    Hollox EJ, Armour JA, Barber JC. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet. 2003;73:591–600.PubMedCrossRefGoogle Scholar
  21. 21.
    Aldred PM, Hollox EJ, Armour JA. Copy number polymorphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3. Hum Mol Genet. 2005;14:2045–2052.PubMedCrossRefGoogle Scholar
  22. 22.
    Mars WM, Patmasiriwat P, Maity T, Huff V, Weil MM, Saunders GF. Inheritance of unequal numbers of the genes encoding the human neutrophil defensins HP-1 and HP-3. J Biol Chem. 1995;270:30371–30376.PubMedCrossRefGoogle Scholar
  23. 23.
    Linzmeier RM, Ganz T. Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22–p23. Genomics. 2005;86:423–430.PubMedCrossRefGoogle Scholar
  24. 24.
    Fellermann K, Stange DE, Schaeffeler E, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet. 2006;79:439–448.PubMedCrossRefGoogle Scholar
  25. 25.
    Bentley RW, Pearson J, Gearry RB, et al. Association of higher DEFB4 genomic copy number with Crohn’s disease. Am J Gastroenterol. 2010;105:354–359.PubMedCrossRefGoogle Scholar
  26. 26.
    Hollox EJ, Huffmeier U, Zeeuwen PL, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet. 2008;40:23–25.PubMedCrossRefGoogle Scholar
  27. 27.
    Hollox EJ. Copy number variation of beta-defensins and relevance to disease. Cytogenet Genome Res. 2008;123:148–155.PubMedCrossRefGoogle Scholar
  28. 28.
    Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8–15.PubMedCrossRefGoogle Scholar
  29. 29.
    Csillag C, Nielsen OH, Borup R, Nielsen FC, Olsen J. Clinical phenotype and gene expression profile in Crohn’s disease. Am J Physiol Gastrointest Liver Physiol. 2007;292:G298–G304.PubMedCrossRefGoogle Scholar
  30. 30.
    Vind I, Vieira A, Hougs L, et al. NOD2/CARD15 gene polymorphisms in Crohn’s disease: a genotype-phenotype analysis in Danish and Portuguese patients and controls. Digestion. 2005;72:156–163.PubMedCrossRefGoogle Scholar
  31. 31.
    Day DW, Jass JR, Price AB, et al. Morson and Dawson’s gastrointestinal pathology. 4th ed. Oxford: Blackwell Science; 2003:505–507.CrossRefGoogle Scholar
  32. 32.
    Spiller R. Clinical update: irritable bowel syndrome. Lancet. 2007;369:1586–1588.PubMedCrossRefGoogle Scholar
  33. 33.
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408.PubMedCrossRefGoogle Scholar
  34. 34.
    Nuytten H, Cuppens H, Verleden G. A high diploid DEFA1A3 copy number predispose to lung transplant rejection. J Heart Lung Transplant. 2009;28:S106.CrossRefGoogle Scholar
  35. 35.
    Hollox EJ. Beta-defensins and Crohn’s disease: confusion from counting copies. Am J Gastroenterol. 2010;105:360–362.PubMedCrossRefGoogle Scholar
  36. 36.
    Ballana E, Gonzalez JR, Bosch N, Estivill X. Inter-population variability of DEFA3 gene absence: correlation with haplotype structure and population variability. BMC Genomics. 2007;8:14.PubMedCrossRefGoogle Scholar
  37. 37.
    Blomqvist M, Bergquist J, Westman A, et al. Identification of defensins in human lymphocyte nuclei. Eur J Biochem. 1999;263:312–318.PubMedCrossRefGoogle Scholar
  38. 38.
    Dooley TP, Curto EV, Reddy SP, et al. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis. 2004;10:1–14.PubMedCrossRefGoogle Scholar
  39. 39.
    Henrichsen CN, Chaignat E, Reymond A. Copy number variants, diseases and gene expression. Hum Mol Genet. 2009;18:R1–R8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Cathrine Jespersgaard
    • 1
  • Peder Fode
    • 2
  • Marianne Dybdahl
    • 1
  • Ida Vind
    • 3
  • Ole Haagen Nielsen
    • 3
  • Claudio Csillag
    • 3
  • Pia Munkholm
    • 3
  • Ben Vainer
    • 5
  • Lene Riis
    • 3
  • Margarita Elkjaer
    • 3
  • Natalia Pedersen
    • 3
  • Elisabeth Knudsen
    • 6
  • Paal Skytt Andersen
    • 4
  1. 1.Department of Clinical Biochemistry and ImmunologyStatens Serum InstitutCopenhagenDenmark
  2. 2.Laboratory for Microbial Pathogenesis and Host Susceptibility, Department for Microbiological Surveillance and ResearchStatens Serum InstitutCopenhagenDenmark
  3. 3.Department of Gastroenterology, Medical SectionHerlev HospitalHerlevDenmark
  4. 4.Laboratory for Microbial Pathogenesis and Host Susceptibility, Department for Microbiological Surveillance and ResearchStatens Serum InstitutCopenhagen SDenmark
  5. 5.Department of Pathology, RigshospitaletUniversity of CopenhagenCopenhagenDenmark
  6. 6.Department of GastroenterologyGlostrup University HospitalGlostrupDenmark

Personalised recommendations